We studied glycoprotein content of human colonic goblet cells, using a library of monoclonal antibodies (MAbs) Anti-HCM MAbs stained goblet cells from other sites within the gastrointestinal tract to a varying extent. Anti-HCM MAbs also showed extensive cross-reactivity with rodent, rabbit, and monkey colonic mucosa. However, several anti-HCM MAbs stained only human colonic mucosa. These data show that human colonic mucosa contains discrete subpopulations of goblet cells that produce distinctive combinations of specific mucin glycoprotein species.
Introduction
The colonic epithelium is an important site of interaction between man and his environment. In addition to containing smaller populations of endocrine cells, the colonic mucosa appears to be composed of seemingly homogeneous populations of epithelial colonocytes and goblet cells (1) (2) (3) (4) . Despite the recognition that alterations may exist in goblet cell glycoproteins in association with a variety of disease processes (5-1 1), there is little basic understanding of normal goblet cell function (12) (13) (14) . It is unclear whether the-enormous population of goblet cells found throughout the colon is functionally homogeneous or instead contains distinct subpopulations. Recent morphologic studies suggest that epithelial cells themselves may represent a subpopulation of colonic goblet cells (12) . Regional differences between goblet cells ofthe ascending and descending colon have been suggested on the basis of histochemical staining patterns (2, 10, 12, 15) and within individual colonic crypts, goblet cells from the upper portion of the gland may be distinguished from those of the lower crypt using fluoresceinated lectin probes (16, 17) . Nonetheless, it remains unclear whether goblet cells are functionally homogeneous or heterogeneous.
While it has long been recognized that mucin glycoprotein is the most abundant goblet cell product, there has been little detailed information on its composition and structure. Recent work in this laboratory has shown that the colonic mucosa collectively produces a complex mixture of at least six compositionally and structurally distinct mucin glycoproteins (mucin species I-VI) (9, 18, 19) . However, the cellular basis of mucin glycoprotein heterogeneity remains unknown. It is unclear whether the spectrum of mucin species I-VI are produced coordinately by all goblet cells or whether alternatively they represent the products of discrete subpopulations of colonic crypts or individual goblet cells. In this report we describe the results of studies in which the heterogeneity of colonic goblet cells and their content of mucin glycoprotein has been examined using a library of anti-human colonic mucin (HCM)' monoclonal antibodies (MAbs) (20) . These studies suggest that there are functionally distinct subclasses within otherwise morphologically homogeneous populations of human colonic goblet cells.
Methods
Preparation and characterization of anti-HCM MAbs. A library of 23 anti-HCM MAbs (7 IgM, 7 IgG,, and 9 IgG2) was isolated by double cloning at limiting dilutions of hybridomas produced from splenocytes of Balb/c mice immunized with pure whole human colonic mucin (20).
The characteristics of this library may be briefly summarized: all MAbs bound pure HCM in a solid-phase radioimmunoassay (RIA). Recognition of separated HCM species I-VI by individual MAbs was assessed by solid-phase sandwich RIA: four bound single HCM species, five did not appear to bind any separated HCM species, and the remainder recognized various combinations oftwo to six ofthe individual HCM species. Structural determinants specified by some MAbs were identified by competitive RIA using oligosaccharides isolated from HCM species. Among the 18 MAbs that bound one or more isolated HCM species, it was possible to define the structural determinants recognized by 12 MAbs. These encompassed a range of intact oligosaccharides or components of oligosaccharides of defined structure isolated from the predominant HCM species III, IV, and V. In addition to the 12 MAbs specifying defined oligosaccharide determinants, four anti-HCM MAbs appeared to be directed to peptide cores or determinants requiring an intact peptide configuration. The structural determinants specified by the remainder ofthe anti-HCM MAbs could not be defined. Spent MAb containing media or MAbs purified from ascites were prepared as described (20) .
Tissue samples. Pinch mucosal biopsy specimens were obtained from patients undergoing diagnostic flexible sigmoidoscopy, colonoscopy, or esophagogastroduodenoscopy at Massachusetts General Hospital, Boston, MA. Biopsy specimens were obtained at the same time that sampling was performed for routine histologic examination. Diagnostic classification of samples included in these studies as normal was made on the basis of the examining physicians' reports and the official interpretation of diagnostic biopsy specimens by members of the Pathology Department at Massachusetts General Hospital. Tissue samples from other sites (e.g., small intestine, gallbladder) were obtained from fresh surgical specimens. These studies were approved by the Human Studies Committee of Massachusetts General Hospital.
Samples of colonic and small intestinal mucosa were obtained from outbred rats (Charles River Breeding Laboratories, Wilmington, MA) and New Zealand white rabbits, after sacrifice by intraperitoneal injection of sodium pentobarbital; samples from cotton-top tamarins (S. oedipus) were obtained after anesthetization as previously described (19) . All samples were promptly processed for immunofluorescent studies as described below.
Indirect immunofluorescence. Multiple frozen sections (2 Am) were prepared from tissue specimens embedded in OCT compound (Miles Laboratories, Naperville, IL) for indirect immunofluorescent (IIF) staining. Initial pilot studies showed no improvement in IlF staining characteristics in sections fixed in 1% formaldehyde before staining when compared with unfixed sections, and therefore prestaining fixation was not routinely employed. After equilibration at room temperature, one drop of anti-HCM MAb containing ascites, diluted 1:100 with phosphatebuffered saline (PBS), or spent anti-HCM MAb culture medium supernatant was added to cover individual tissue sections, and slides were placed in a moist chamber at room temperature for 30 min. Control sections were incubated with ascites or media derived from the parent NSl myeloma line. Subsequently, ascites or media were aspirated and sections were washed three times by immersion in excess PBS. After air drying, sections were routinely stained by addition of fluorescein isothiocyanate (FITC-conjugated rabbit anti-mouse Ig (Cappel Laboratories, Cochranville, PA) diluted 1:25 with PBS. In double-labeling experiments, staining was accomplished using FITC and rhodamine red-conjugated goat anti-mouse F(ab')2 specific for mouse immunoglobulin heavy chains (gamma or mu chain). Pilot studies demonstrated equivalent IIF staining in double-labeling experiments if conjugated antisera were added sequentially or simultaneously, and the latter was therefore used routinely. After incubation at room temperature for 30 min in a moist chamber, excess reagent was aspirated and sections were washed again as before.
Tissue was counterstained with Evans Blue and fluorescent staining evaluated using a fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY). Quantitative estimates of goblet cell and crypt staining were determined as the percentage of cells stained in 10 high power fields (40 X objective) or lower power fields (10 X objective), respectively. The coefficient of variation between fields was found to be ± 12%.
Results
In these studies, anti-HCM MAbs were used to examine tissue localization of HCM species by means of indirect immunofluorescent techniques. Among 23 anti-HCM MAbs, 17 a individual cells were consistent within specimens; e.g., all cells stained by MAb 2 showed diffuse staining of the intracellular mucin droplet and not other staining patterns. Specific staining characteristics of each anti-HCM MAb were also consistent among mucosal samples ofnormal sigmoid colon from different patients (n = 9). The staining patterns of individual anti-HCM MAbs in normal human sigmoid colon are summarized in Table  II . There were no consistent associations between species specificities ofMAbs as determined by solid-phase RIA and particular patterns of cellular IIF staining (cf . Tables I and II) . The latter point is illustrated by MAbs 4 and 5, which both bind species IV yet showed different cellular staining patterns. In this context, it should be noted that these MAbs recognize different and distinct epitopes as indicated by the different patterns of binding to other HCM species in solid-phase assays. Some anti-HCM MAbs that were specific for single HCM species failed to demonstrate any appreciable 1IF staining; and MAbs that were positive for IIF staining but failed to bind separated mucin fractions in solid-phase RIA, demonstrated a range of staining patterns.
In addition to the differences in the manner of staining of individual cells, anti-HCM MAbs varied in the proportion of goblet cells stained within and between individual colonic crypts as shown in the representative photomicrographs of Fig. 2 . 10 MAbs were found to effect "uniform" goblet cell staining defined as >95% of cells stained in >95% of crypts of normal sigmoid mucosa (e.g., MAb 3; Fig. 2 A) . Three anti-HCM MAbs stained goblet cells in every crypt (>95%) but within individual crypts not all goblet cells were stained (<70%) (e.g., MAb 7; Fig. 2 B) , a crypt staining pattern designated "dispersed." Finally, four anti-HCM MAbs stained mucosa in a "limited" pattern defined as staining <70% of individual cells, with fewer than 70% of crypts containing stained goblet cells. Thus, there was complete absence of staining in some crypts by MAbs exhibiting the "limited" staining pattern.
Patterns of crypt staining observed for the library of anti-HCM MAbs, referred to as "uniform," "dispersed," and "limited," and the data from which these designations were derived, are detailed in (Tables II and III) . Furthermore, heterogeneity of goblet cell staining by those MAbs As demonstrated in a representative photomicrograph (Fig.  3 A) , goblet cells exhibited simultaneous staining for two anti-HCM MAbs of differing species specificity, which suggests that these cells contain more than one mucin. Therefore, individual goblet cells seemed to be able to produce more than one mucin species. Note that anti-HCM MAbs used in double staining studies included those with demonstrated specificity for more extended intrinsic structural components of HCM (i.e., whole oligosaccharide side chain), and these served as reliable probes for the presence of specific HCM species. Nonetheless, pairs of mucin species were not invariably associated in every goblet cell; some goblet cells in the same tissue section were stained by only one of the pair of anti-HCM MAbs. Additional doublelabeling experiments suggested that some mucin species were found in mutually exclusive subpopulations of goblet cells; e.g., simultaneous incubation with MAbs selective for HCM species III (MAb 7) and V (MAb 6) showed staining of different goblet cells by the two probes (Fig. 3 B) .
In summary, it appeared that species III did not coexist with IV or V within single goblet cells, but seemed to be restricted to nonoverlapping goblet cell populations. However, goblet cells containing each of these species did consistently contain other remaining HCM species (I, II, and VI). Collectively, the double IIF staining studies using pairs of anti-HCM MAb allowed delineation of a number of subsets of goblet cells distinguished by their content of different combinations of HCM species (see Table V). None of these subpopulations were localized to specific areas ofthe mucosal surface or crypts, but rather, they appeared dispersed throughout the colonic surface. In view of the limitations of the IIF technique described above, the variety of sub- 
Discussion
It has long been recognized on the basis of histochemical studies that mucin glycoproteins are the most abundant products of colonic goblet cells (21) (22) (23) (24) . Early studies suggested that these substances were heterogeneous but it was unclear whether polydispersity detected by conventional analytic tools (e.g., sedimentation centrifugation) reflected important biological diversity (25) (26) (27) (28) (29) . More recent studies from this laboratory showed the presence of at least six chromatographically distinct HCM subclasses (9, 18 Human Colon Rectum (n = 9) 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 Sigmoid (n = 9) 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 Transverse (n = 6) 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Cecum(n = 6) 100 100 100 100 100 100 100 100 100 100 100 100 100 100 Ileum (n = 7) 100 100 100 100 100 86 100 72 Duodenum/Jejunum (n = 4) 100 100 75 75 100 Stomach (n = 4) 100 75 Gallbladder (n = 3) 100
Rat Colon (n = 3) 100 100 100 100 67 100 100 67 67
Small intestine (n = 3) 100 100 67 33 67
Rabbit Colon (n = 3) 100 100 100 100 Small intestine (n = 3) 100 67
Monkey Colon(n = 2) 100 100 100 100 100 100 100 100 50 100 * Properties of individual MAbs described in Table I . Pattern of staining by individual MAbs described in Table II Findings obtained with anti-HCM MAbs differ from those of earlier studies using lectins, histochemical stains, or conventional antisera, which suggested the presence of gradations of mucin glycoproteins both along the length of the colon (e.g., increasing acidic mucosubstances in the left colon and neutral in the right) or within individual colonic crypts (2, 6, 15, 16, (31) (32) (33) . However, these earlier approaches used reagents directed against limited peripheral structural components, such as sulfate or terminal carbohydrate residues. Solid-phase RIA binding studies with anti-HCM MAbs suggest that probes which recognize only limited peripheral structural determinants may lead to distinctions unrelated to significant structural differences. Interestingly, anti-HCM MAbs directed to nonspecific peripheral oligosaccharide determinants showed some regional variations in staining patterns comparable to those observed with these earlier methods. These findings emphasize the importance of defining the structural antigenic determinants specified by probes before the biological significance ofstaining or binding phenomena can be meaningfully assessed.
Despite the differences between patterns of mucin heterogeneity observed with anti-HCM MAbs and other methods within the colonic mucosa, the increasing cross-reactivity ofanti-HCM MAbs at progressively more distal sites of the gastrointestinal tract is comparable to the results of earlier studies (29, 34) . The present studies confirm the impression that some structural features are common to all gastrointestinal tract mucin, while other components of mucin may represent organ specific determinants. Note that the similarity between animal and human colonic mucin was greater than that observed between human colon and more proximal areas of the human digestive tract, which supports the concept that colonic mucin structure is related to specific colonic functions. Although no HCM species was found to be localized to a specific region of the colon, HCM species IV containing goblet cells appeared to be present in greater numbers at more distal sites although the difference did not achieve the level ofstatistical significance. The distribution of mucin species IV containing goblet cells is interesting in view ofthe demonstrated association between reductions in this component and ulcerative colitis, a disorder in which there is preferential involvement of the distal colon. This observation raises the intriguing possibility that there may be a reduction or functional alteration of particular goblet cell subpopulations in association with specific disease processes; and studies are currently underway using these techniques to examine goblet cell heterogeneity in patients with ulcerative colitis as well as in other disorders. However, the limitations of the essentially qualitative methods used in these studies should be emphasized. The present methods do not precisely quantify all anti-HCM MAb defined goblet subtypes. They also do not quantify the amount of each substance within individual cells.
Despite the demonstrated association of a particular disease process with selective reduction in one mucin species, the functional roles of discrete mucin species remain unknown. Neutra and co-workers (35) (36) (37) (38) have demonstrated that mucin production and secretion may be subject to a variety of neural and hormonal control mechanisms. They have suggested that patterns of responsiveness to various mediators may define functional subclasses of colonic goblet cells. It will be interesting to determine whether the goblet cells producing different HCM species are subject to different control mechanisms. Insight into the functional significance ofthese distinctions will also depend on more detailed understanding of the peptide and oligosaccharide structures of HCM species. Anti-mucin MAbs may facilitate attempts to prepare enriched subpopulations of colonic goblet cells. Collectively, the present studies indicate the presence of previously unappreciated heterogeneity among colonic goblet cells.
